Cite
HARVARD Citation
Kolibaba, K. et al. (2013). Demographics, treatment patterns, safety, and real-world effectiveness in patients aged 70 years and over with chronic lymphocytic leukemia receiving bendamustine with or without rituximab: a retrospective study. Therapeutic advances in hematology. pp. 157-171. [Online].